Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Works by Seppälä, Niko
Results: 10
1
2
Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine.
- Published in:
- Nordic Journal of Psychiatry, 2017, v. 71, n. 2, p. 89, doi. 10.1080/08039488.2016.1230649
- By:
- Publication type:
- Article
3
Factors associated with subjective side-effects during clozapine treatment.
- Published in:
- Nordic Journal of Psychiatry, 2015, v. 69, n. 3, p. 161, doi. 10.3109/08039488.2014.947321
- By:
- Publication type:
- Article
4
Smoking and weight among patients using clozapine.
- Published in:
- Nordic Journal of Psychiatry, 2014, v. 68, n. 8, p. 620, doi. 10.3109/08039488.2014.907340
- By:
- Publication type:
- Article
5
Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 4, p. 336, doi. 10.1002/hup.2408
- By:
- Publication type:
- Article
6
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection.
- Published in:
- Schizophrenia Research & Treatment, 2012, p. 1, doi. 10.1155/2012/791468
- By:
- Publication type:
- Article
7
CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
- Published in:
- BMC Psychiatry, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-244X-14-50
- By:
- Publication type:
- Article
8
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.
- Published in:
- CNS Drugs, 2022, v. 36, n. 9, p. 1015, doi. 10.1007/s40263-022-00946-w
- By:
- Publication type:
- Article
9
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.
- Published in:
- CNS Drugs, 2022, v. 36, n. 7, p. 659, doi. 10.1007/s40263-022-00932-2
- By:
- Publication type:
- Article
10
Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients.
- Published in:
- Acta Neuropsychiatrica, 2024, v. 36, n. 4, p. 218, doi. 10.1017/neu.2024.9
- By:
- Publication type:
- Article